EDIT earnings: a positive outcome, +18.2%

On November 3, 2023, Editas Medicine, Inc. reached its earnings. The result was a positive outcome, and the stock moved +18.2% in the window around the event. It had already run -5.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.